Montiès J R, Havlik P, Mesana T, Trinkl J, Tourres J L, Demunck J L
Laboratory for Surgical Research, University of Aix-Marseilles II, School of Medicine, France.
Artif Organs. 1994 Jul;18(7):506-11. doi: 10.1111/j.1525-1594.1994.tb03368.x.
We have developed a low-speed, double-lobed hypocycloidal pump that furnishes a pulsatile flow without valves. The pump is coupled to a specially designed electric motor. The motor/pump unit is totally implantable and has been extensively tested in vitro and in vivo in animals. Because this pump is volumetric, it is necessary to control speed precisely to avoid overpumping. Our control system, which is based on analysis of the motor current wave form, can detect and prevent negative pressures before they occur. The physical properties and hemocompatibility of several construction materials have been studied to determine their suitability for clinical use. These materials include a graphite substrate, titanium nitrate surface coating, boric carbon, and amorphous diamond. The pumps currently being tested are made of titanium, but clinical versions will be made of composite materials selected from this preliminary study. In vivo testing of this pump confirmed its good hemodynamic performance, low hemolysis rate, and biocompatibility (i.e., low heat, noise, and vibration levels). Animal experiments were terminated after 15 days because of mechanical failure related to the accumulation of blood components on moving parts. A new pump in which the mechanism is completely sealed from the blood flow has been designed and will soon be tested. If this sealed design is effective, the pump should be ready for use as a permanent implantable ventricular assistance device.
我们研发了一种低速、双叶摆线泵,该泵无需阀门即可提供脉动血流。该泵与一台专门设计的电动机相连。电机/泵单元完全可植入,并且已经在动物身上进行了广泛的体外和体内测试。由于这种泵是容积式的,因此有必要精确控制速度以避免过度泵送。我们基于电机电流波形分析的控制系统能够在负压出现之前进行检测并防止其发生。已经研究了几种建筑材料的物理特性和血液相容性,以确定它们是否适合临床使用。这些材料包括石墨基底、硝酸钛表面涂层、硼碳和非晶金刚石。目前正在测试的泵由钛制成,但临床版本将由从这项初步研究中选择的复合材料制成。该泵的体内测试证实了其良好的血液动力学性能、低溶血率和生物相容性(即低热、噪音和振动水平)。由于与运动部件上血液成分积累相关的机械故障,动物实验在15天后终止。已经设计了一种新泵,其机械装置与血流完全密封,很快将进行测试。如果这种密封设计有效,该泵应该可以作为永久性可植入心室辅助装置投入使用。